HCW Biologics Inc. (HCWB) vs China SXT Pharmaceuticals, Inc. (SXTC)

A side-by-side comparison of HCW Biologics Inc. and China SXT Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HCWB

HCW Biologics Inc.

$552784

$1.59HealthcareDelayed quote: Oct 6, 2026, 1:51 PM EDT

SXTC

China SXT Pharmaceuticals, Inc.

$862370

$1.62HealthcareDelayed quote: Oct 6, 2026, 1:48 PM EDT

Total return — HCWB vs SXTC

growth of $100 · dividends reinvested · last 5y

HCWB -99.8% (-70.6%/yr)SXTC -100.0% (-95.7%/yr)HCWB compounded faster over this window

Log scale — wide-divergence pair

HCWB SXTC

Metrics side by side

Total return (annualized)

Metric	HCWB	SXTC
Total return (1Y)	-93.15%	N/A
Total return CAGR (3Y)	-84.70%	N/A
Total return CAGR (5Y)	-69.71%	N/A

SXTC is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full HCWB analysis Full SXTC analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.